On April 1, 2025, Abbott India Limited announced the appointment of Devesh Choudhari as Director - Finance, effective immediately. This appointment follows the recommendation of the Nomination and Remuneration Committee and approval by the Board of Directors. Devesh will join the senior management team at Abbott India, bringing with him a wealth of experience in the financial domain.

Devesh Choudhari is a seasoned finance professional with 18 years of experience, specializing in a variety of financial functions, including finance, accounting, structuring, and M&A. His career trajectory showcases a proven track record of successfully leading complex financial projects and business transformations across industries.

Prior to joining Abbott India, Devesh served as the Chief Financial Officer (CFO) at Perfect Day, a US-based food biotechnology company. At Perfect Day, he played an instrumental role in managing the company’s Indian manufacturing business following its acquisition of Sterling Biotech. Additionally, he contributed significantly to a $100 million greenfield project that is currently under construction. Devesh was also pivotal in the strategic sale of the company and in forming a joint venture with the Zydus group, where he continued his role as CFO.

Devesh’s experience extends to his nearly decade-long tenure at the Piramal Group, where he gained hands-on experience in managing multi-segment, multi-location manufacturing setups. He also played a critical role in raising over $1.5 billion in equity and contributed to the $4 billion acquisition of DHFL by Piramal, overseeing the integration of its financial operations.

Earlier in his career, Devesh worked with Deloitte in the Assurance function, providing services to leading FMCG, chemical, and pharmaceutical companies. He is a qualified Chartered Accountant and holds a Diploma in International Financial Reporting Standards (IFRS).

This appointment marks a significant milestone for Abbott India as the company continues to strengthen its leadership team. With his rich experience and expertise, Devesh is expected to play a key role in furthering Abbott’s business objectives, particularly in the realms of financial management and strategic growth.

For more details on this announcement and Abbott India’s corporate updates, stakeholders are encouraged to visit the official Abbott India website. The company continues to be committed to excellence and transparency, ensuring that all its appointments align with the SEBI Listing Regulations and corporate governance standards.

The Current active IPO are Aten Papers & Foam Limited, Infonative Solutions Limited,Spinaroo Commercial Limited,Retaggio Industries Limited.

The Closed IPOs are  Identixweb Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in .Choice Broking FinX

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.